Results 201 to 210 of about 219,425 (233)
Some of the next articles are maybe not open access.
Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model.
Journal of Urology, 2009 J. Fernández-Gómez, R. Madero, E. Solsona, M. Unda, L. Martínez-Piñeiro, Marcelino González, J. Portillo, A. Ojea, C. Pertusa, J. Rodríguez-Molina, J. E. Camacho, M. Rabadán, A. Astobieta, M. Montesinos, S. Isorna, P. Muntañola, A. Gimeno, M. Blas, J. Martinez-Pineiro +18 moresemanticscholar +1 more sourceA multicentre, randomised prospective trial comparing three intravesical adjuvant therapies for intermediate-risk superficial bladder cancer: low-dose bacillus Calmette-Guerin (27 mg) versus very low-dose bacillus Calmette-Guerin (13.5 mg) versus mitomycin C.
European Urology, 2007 A. Ojea, J. L. Nogueira, E. Solsona, N. Flores, J. Gómez, J. R. Molina, V. Chantada, J. E. Camacho, L. Piñeiro, R. H. Rodríguez, S. Isorna, M. Blas, J. Martinez-Pineiro, R. Madero +13 moresemanticscholar +1 more sourceHas a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial.
Journal of Urology, 2005 J. Martinez-Pineiro, L. Martínez-Piñeiro, E. Solsona, R. H. Rodríguez, J. Gómez, Marcelino González Martín, J. R. Molina, A. Collado, N. Flores, S. Isorna, C. Pertusa, M. Rabadán, A. Astobieta, J. E. Camacho, Salvador Arribas, R. Madero +15 moresemanticscholar +1 more sourceLong‐term follow‐up of a randomized prospective trial comparing a standard 81 mg dose of intravesical bacille Calmette‐Guérin with a reduced dose of 27 mg in superficial bladder cancer
BJU International, 2002 Martínez-Piñeiro Ja, N. Flores, S. Isorna, E. Solsona, J. L. Sebastián, C. Pertusa, R. La, Luis Martínez-Piñeiro, R. Vela, J. E. Camacho, J. L. Nogueira, I. Pereira, L. Resel, P. Muntañola, F. Galvis, N. Chesa, J. A. Torres, J. Carballido, C. Bernuy, Salvador Arribas, R. Madero +20 moresemanticscholar +1 more sourcePrognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials.
European Urology, 2008 J. Fernández-Gómez, E. Solsona, M. Unda, L. Martínez-Piñeiro, Marcelino González, R. Hernandez, R. Madero, A. Ojea, C. Pertusa, J. Rodríguez-Molina, J. E. Camacho, S. Isorna, M. Rabadán, A. Astobieta, M. Montesinos, P. Muntañola, A. Gimeno, M. Blas, J. Martinez-Pineiro +18 moresemanticscholar +1 more source